Identification and functional characterization of a Na+-independent large neutral amino acid transporter, LAT1, in human and rabbit cornea

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 7, 2003, Pages 2919-2927

  Jain Vakkalagadda, Blisse ^b   Dey, Surajit ^b   Pal, Dhananjay ^b   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOBICYCLO[2.2.1]HEPTANE 2 CARBOXYLIC ACID; ALANINE; AMINO ACID; AMINO ACID TRANSPORTER; LEUCINE; OUABAIN; PHENYLALANINE; RNA; SODIUM; SODIUM AZIDE;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE TRANSPORT; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CORNEA; CORNEA EPITHELIUM; ENERGY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACIDS, CYCLIC; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CORNEA; DIPEPTIDES; EPITHELIUM, CORNEAL; EYE PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MALE; OUABAIN; PHENYLALANINE; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM AZIDE; SODIUM CHLORIDE;

EID: 0038577060     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0907     Document Type: Article

References (66)

1. Klyce SD, Crosson CE. Transport processes across the rabbit corneal epithelium: a review. Curr Eye Res. 1985;4:323-330.
2. Grass GM, Robinson JR. Mechanisms of corneal drug penetration. I: in vivo and in vitro kinetics. J Pharm Sci. 1988;77:3-14.
3. Grass GM, Robinson JR. Mechanisms of corneal drug penetration. II: ultrastructural analysis of potential pathways for drug movement. J Pharm Sci. 1988;77:15-23.
4. Sieg, JW, Robinson JR. Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone. J Pharm Sci. 1975;64:931-936.
5. Lee VH. Membrane transporters. Eur J Pharm Sci. 2000;11(suppl 2):S41-S50.
6. Bolger MB, Haworth IS, Yeung AK, et al. Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1. J Pharm Sci. 1998;87:1286-1291.
7. Tamura K, Lee CP, Smith PL, et al. Effect of charge on oligopeptide transporter-mediated permeation of cyclic dipeptides across Caco-2 cell monolayers. Pharm Res. 1996;13:1752-1754.
8. Martel F, Grundemann D, Calhau C, et al. Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters. Naunyn Schmiedebergs Arch Pharmacol. 2001;363:40-49.
9. Huber K, Walter C, Schroder B, et al. Epithelial phosphate transporters in small ruminants. Ann NY Acad Sci. 2000;915:95-97.
10. Tsuji A, Tamai I. Carrier-mediated intestinal transport of drugs. Pharm Res. 1996;13:963-977.
11. Oh DM, Han HK, Amidon GL. Drug transport and targeting: intestinal transport. Pharm Biotechnol. 1999;12:59-88.
12. +/monocarboxylate transporters. J Biol Chem. 2001;276:17221-17228.
13. Tamai I, Tsuji A. Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci. 2000;89:1371-1388.
14. +-dependent L-arginine transport in the pigmented rabbit conjunctiva. Exp Eye Res. 1997;65:547-553.
15. Hosoya K, Horibe Y, Kim KJ, et al. Nucleoside transport mechanisms in the pigmented rabbit conjunctiva. Invest Ophthalmol Vis Sci. 1998;39:372-377.
16. +-coupled amino acid transport in the pigmented rabbit conjunctiva. Life Sci. 1995;57:1427-1431.
17. Rajan PD, Kekuda R, Chancy CD, et al. Expression of the extraneuronal monamine transporter in RPE and neuronal retina. Curr Eye Res. 2000;20:195-204.
18. Pow DV. Amino acids and their transporters in the retina. Neurochem Int. 200;38:463-484.
19. Gu S, Roderick HL, Camacho P, et al. Characterization of an N-system amino acid transporter expressed in retina and its involvement in glutamine transport. J Biol Chem. 2001;276:24137-24144.
20. Harada T, Harada C, Watanabe M, et al. Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc Natl Acad Sci USA. 1998;95:4663-4666.
21. Bonanno JA. Lactate-proton cotransport in rabbit corneal epithelium. Curr Eye Res. 1990;9:707-712.
22. Takahashi H, Kaminski AE, Zieske JD. Glucose transporter 1 expression is enhanced during corneal epithelial wound repair. Exp Eye Res. 1996;63:649-659.
23. Takahashi H, Ohara K, Ohmura T, et al. Glucose transporter 1 expression in corneal wound repair under high serum glucose level. Jpn J Ophthalmol. 2000;44:470-474.
24. Anand BS, Mitra AK. Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea. Pharm Res. 2002;19:1194-1202.
25. Christensen HN, Albritton LM, Kakuda DK, et al. Gene-product designations for amino acid transporters. J Exp Biol. 1994;196:51-57.
26. Broer S, Wagner CA, Lang F. Function and structure of heterodimeric amino acid transporters. Am J Physiol. 2001;281: C1077-C1093.
27. Palacin M, Estevez R, Bertran J, et al. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev. 1998;78:969-1054.
28. Deves R, Boyd CA. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev. 1998;78:487-545.
29. O. Am J Physiol. 1997;272:G1463-G1472.
30. +L: a candidate gene for lysinuric protein intolerance. J Biol Chem. 1998;273:32437-32445.
31. +L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. EMBO J 1999;18:49-57.
32. O from a human placental choriocarcinoma cell line. J Biol Chem. 1996;271:18657-18661.
33. Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev. 1990;70:43-77.
34. Yanagida O, Kanai Y, Chairoungdua, et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta. 2001;1514:291-302.
35. Goldenberg GJ, Lam HY, Begleiter A. Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro. J Biol Chem. 1979;254:1057-1064.
36. Lakshmanan M, Goncalves E, Lessly G, et al. The transport of thyroxine into mouse neuroblastoma cells, NB41A3: the effect of L-system amino acids. Endocrinology. 1990;126:3245-3250.
37. Blondeau JP, Beslin A, Chantoux F, et al. Triiodothyronine is a high-affinity inhibitor of amino acid transport system L1 in cultured astrocytes. J Neurochem. 1993;60:1407-1413.
38. Patel A, Uhl G, Kuhar MJ. Species differences in dopamine transporters: postmortem changes and glycosylation differences. J Neurochem. 1993;61:496-500.
39. Su TZ, Lunney E, Campbell G, et al. Transport of gabapentin, a gamma-amino acid drug, by system L alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells. J Neurochem. 1995;64:2125-2131.
40. Hargreaves KM, Pardridge WM. Neutral amino acid transport at the human blood-brain barrier. J Biol Chem. 1988;263:19392-19397.
41. Pineda M, Fernandez E, Torrents E, et al. Identification of a membrane protein, LAT2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem. 1999;274:19738-19744.
42. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem. 1999;274:19745-19751.
43. +-independent broad-specific neutral amino acid transporter from mammalian intestine. Biochim Biophys Acta. 2000;1463:6-14.
44. Kageyama T, Nakamura M, Matsuo A, et al. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res. 2000;879:115-121.
45. +-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. J Biol Chem. 2000;275:9690-9698.
46. Verrey F, Meier C, Rossier G, et al. Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity. Pflugers Arch. 2000;440:503-512.
47. Kanai Y, Segawa H, Miyamoto K, et al. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem. 1998;273:23629-23632.
48. Goskonda VR, Hill RA, Khan MA, et al. Permeability of chemical delivery systems across rabbit corneal (SIRC) cell line and isolated corneas: a comparative study. Pharm Dev Technol. 2000;5:409-416.
49. Goskonda VR, Khan MA, Hutak CM, et al. Permeability characteristics of novel mydriatic agents using an in vitro cell culture model that utilizes SIRC rabbit corneal cells. J Pharm Sci. 1999;88:180-184.
50. Niederkorn JY, Meyer DR, Ubelaker JE, et al. Ultrastructural and immunohistological characterization of the SIRC corneal cell line. In Vitro Cell Dev Biol. 1990;26:923-930.
51. Blein-Sella O, Adolphe M. SIRC cytotoxicity test. Methods Mol Biol. 1995;43:161-167.
52. + exchange in a rabbit corneal epithelial cell line (SIRC). Biochim Biophys Acta. 1988;943:405-410.
53. Grabner G, Luger TA, Luger BM, et al. Biologic properties of the thymocyte-activating factor (CETAF) produced by a rabbit corneal cell line (SIRC). Invest Ophthalmol Vis Sci. 1983;24:589-595.
54. Phillips CA, Melnick JL, Burkhardt M. Isolation, propagation and neutralization of rubella virus in cultures of rabbit cornea (SIRC) cells. Proc Soc Exp Biol Med. 1966;122:783-786.
55. Tak RV, Pal D, Gao H, et al. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. J Pharm Sci. 2001;90:1505-1515.
56. Surendran N, Covitz KM, Han H, et al. Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist. Pharm Res. 1999;16:391-395.
57. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem. 1976;72:248-254.
58. Hidalgo IJ, Borchardt RT. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. Biochim Biophys Acta. 1990;1028:25-30.
59. Sugawara M, Nakanishi T, Fei YJ, et al. Cloning of an amino acid transporter with functional characteristics and tissue expression pattern identical to that of system A. J Biol Chem. 2000;275:16473-16477.
60. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
61. Ganapathy V, Brandch M, Leibach FH. Intestinal transport of amino acids and peptides. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 3rd ed. New York: Raven Press; 1994:1773-1794.
62. Sershen H, Latha A. Inhibition pattern by analogs indicates the presence of ten or more transport systems for amino acids in brain cells. J Neurochem. 1979;32:719-726.
63. Shotwell MA, Jayme DW, Kilberg MS, et al. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem. 1981;256:5422-5427.
64. Prasad PD, Wang H, Huang W, et al. Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res. Commun. 1999;255:283-288.
65. Uchino H, Kanai Y, Kim DK, et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharm. 2002;61:729-737.
66. Balakrishnan A, Jain B, Yang C, et al. Carrier mediated uptake of L-tyrosine and its competitive inhibition by model tyrosine linked compounds in a rabbit corneal cell line (SIRC): strategy for the design of transporter/receptor targeted prodrugs. Int J Pharm. 2002;247:115-125.